Study Design: Conducted as an open, single-center clinical trial, the study involved 25 women aged 18-50 who exhibited common symptoms of brittle nails. This trial followed a daily intake of 2.5g of VERISOL® over a duration of 6 months. Additionally, a four-week observation period followed the intervention to assess any sustained effects.
Key Findings: The results of the study shed light on the positive implications of VERISOL® on fingernails.
- 75% Participants experienced improvements in the quality and growth of their nails, addressing the common issue of brittleness.
- The trial demonstrated the potential of VERISOL® to contribute to overall nail health, a critical factor in the broader spectrum of collagen-related benefits.
Conclusion: Clinical Study IV, conducted as an open, single-center trial over a 6-month period, reveals encouraging findings regarding the positive effects of VERISOL® on the quality and growth of fingernails. This study adds to the growing body of evidence supporting the multifaceted benefits of VERISOL® in promoting overall health and well-being.